Crosstalk between CRISPR-Cas9 and the human transcriptome.
Aaron A SmargonAssael A MadrigalBrian A YeeKevin D DongJasmine R MuellerGene W YeoPublished in: Nature communications (2022)
CRISPR-Cas9 expression independent of its cognate synthetic guide RNA (gRNA) causes widespread genomic DNA damage in human cells. To investigate whether Cas9 can interact with endogenous human RNA transcripts independent of its guide, we perform eCLIP (enhanced CLIP) of Cas9 in human cells and find that Cas9 reproducibly interacts with hundreds of endogenous human RNA transcripts. This association can be partially explained by a model built on gRNA secondary structure and sequence. Critically, transcriptome-wide Cas9 binding sites do not appear to correlate with published genome-wide Cas9 DNA binding or cut-site loci under gRNA co-expression. However, even under gRNA co-expression low-affinity Cas9-human RNA interactions (which we term CRISPR crosstalk) do correlate with published elevated transcriptome-wide RNA editing. Our findings do not support the hypothesis that human RNAs can broadly guide Cas9 to bind and cleave human genomic DNA, but they illustrate a cellular and RNA impact likely inherent to CRISPR-Cas systems.
Keyphrases
- crispr cas
- genome editing
- endothelial cells
- genome wide
- dna damage
- induced pluripotent stem cells
- pluripotent stem cells
- gene expression
- poor prognosis
- systematic review
- dna methylation
- randomized controlled trial
- nucleic acid
- mass spectrometry
- binding protein
- cell free
- single molecule
- long non coding rna
- gestational age